Clinical Trial Update: Efficacy and Bone Safety of Sotagliflozin 400 and 200 mg Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control [Phase 3]

View source ↗

Summary

Phase 3 trial update reports on efficacy and bone safety of sotagliflozin 400 mg and 200 mg vs placebo in type 2 diabetes patients with inadequate glycemic cont…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sotagliflozin (sotagliflozin)

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: TERMINATED | Results posted: 2021-06-25